{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-020177","form_type":"8-K","ticker":"INSM","cik":"0001104506","company_name":"INSMED Inc","filed_at":"2022-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.766734+00:00","generated_at":"2026-06-25T08:04:19.961205+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Insmed appoints Drayton Wise as Chief Commercial Officer; $500k salary, $2.1M equity award","bullets":["Drayton Wise appointed CCO effective May 23, 2022; previously SVP Head of US & GM of ARIKAYCE.","Annual base salary of $500,000; target bonus 40% of base; RSU and option award valued at $2.1M.","RSUs vest 25% per year over four years; options vest 25% on first anniversary then 12.5% semiannually.","Wise to lead all global commercial functions and join Executive Committee; CEO cites brensocatib launch prep."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-020177","json":"https://secwatch.observer/filing/0001140361-22-020177.json","markdown":"https://secwatch.observer/filing/0001140361-22-020177.md","text":"https://secwatch.observer/filing/0001140361-22-020177.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1104506/000114036122020177/0001140361-22-020177-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1104506/000114036122020177/brhc10037965_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T08:04:19.961205+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2b1bdf92d5","claim":"Drayton Wise was appointed as Chief Commercial Officer at INSMED Inc.","evidence_excerpt":"On May 23, 2022, Insmed Incorporated (the “Company”) announced that Mr. Drayton Wise has been appointed as Chief Commercial Officer of the Company, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1104506/000114036122020177/0001140361-22-020177-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}